This inventor holds 24 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Biological Sample Analysis. Top assignees: Accumed International, Inc., Acumed, Inc., Abbott Laboratories Corporation. Active years: 1991-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chicago, IL (US) (2016)
- Libertyville, IL (US) (1991 - 2018)
Company Filing History:
10 out of 15 
6 out of 158 
2 out of 4,189 
Years Active: 1991-2018
Areas of Expertise:
Title: Richard A. Domanik: Innovator in Biological Specimen Evaluation
Introduction: Richard A. Domanik, based in Libertyville, Illinois, is a prolific inventor with an impressive portfolio of 23 patents. His work in the field of cytology and immunology has significantly contributed to the advancement of methods for evaluating biological specimens, particularly in the context of cancer detection and screening.
Latest Patents: Domanik's recent patents showcase his innovative approaches. One notable patent describes biological specimen evaluation methods that utilize cytology and immunology. This technique combines information on cytokines and cytology from biological specimens to assess the risk of dysplasia progressing to cancer. His methodologies enhance the evaluation of biological samples from patients undergoing cancer testing by incorporating cell types and cytokines that are often overlooked in traditional cytological screenings.
Another significant patent is focused on a cervical screening system designed for accurately obtaining cervical cells from patients. This system features a collector that captures a spatially arranged cell sample from targeted tissues. Notably, the patented analyzer examines the cell sample for abnormal cells while it remains on the surface of the collector, ensuring quick and effective screenings.
Career Highlights: Throughout his career, Richard has made substantial contributions to the medical field through his inventions. He has worked for notable companies such as Accumed International, Inc. and Acumed, Inc., where he applied his expertise in medical technology to develop solutions that improve patient care and diagnostics.
Collaborations: Domanik has collaborated with esteemed professionals in his field, including Peter P. Gombrich and William J. Mayer. These partnerships have enabled him to leverage diverse expertise and innovate further in biological specimen evaluation.
Conclusion: Richard A. Domanik stands out as a leading inventor in the realm of biological specimen evaluation. His patents reflect a commitment to enhancing cancer detection methods, which ultimately contributes to improved patient outcomes. The impact of his work will likely continue to resonate within the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile